ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Infectious Disease

Top Infectious Disease Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PARASBHAI PATEL MD

Infectious Disease

20,185

$1.01M

436
343 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 43%

$50
Average prescription price

Avg: $305

TRACY OSBORNE M.D.

Infectious Disease

8,202

$602K

515
397 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 43%

$73
Average prescription price

Avg: $305

STEPHEN RAFFANTI MD

Infectious Disease

6,673

$3.62M

278
29 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 43%

$542
Average prescription price

Avg: $305

JEANETTE ILARDE MD

Infectious Disease

6,472

$338K

362
261 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 43%

$52
Average prescription price

Avg: $305

WYCLIFFE WRIGHT M.D.

Infectious Disease

5,112

$312K

79
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 43%

$61
Average prescription price

Avg: $305

CATHERINE MCGOWAN MD

Infectious Disease

4,833

$2.28M

160
21 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 43%

$471
Average prescription price

Avg: $305

STANLEY BODNER M.D., FACP,DCMT

Infectious Disease

4,123

$1.15M

184
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 43%

$279
Average prescription price

Avg: $305

JAMES SIZEMORE MD

Infectious Disease

3,950

$1.81M

198
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 43%

$459
Average prescription price

Avg: $305

MARGARITA LAMOTHE M.D.

Infectious Disease

2,938

$1.4M

213
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 43%

$477
Average prescription price

Avg: $305

JOHN NARRO MD

Infectious Disease

2,450

$1.8M

161
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 43%

$734
Average prescription price

Avg: $305

DAVID GEORGE MD

Infectious Disease

2,172

$940K

170
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 43%

$433
Average prescription price

Avg: $305

VLADIMIR BERTHAUD M.D.

Infectious Disease

2,019

$952K

64
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 43%

$472
Average prescription price

Avg: $305

LISA LAYA MD

Infectious Disease

1,724

$536K

145
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 43%

$311
Average prescription price

Avg: $305

SYED HUSNAIN MD

Infectious Disease

1,626

$58.7K

147
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 43%

$36
Average prescription price

Avg: $305

MACK LAND M.D.

Infectious Disease

1,483

$831K

88
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 43%

$561
Average prescription price

Avg: $305

MARK RASNAKE MD

Infectious Disease

1,409

$1.01M

113
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 43%

$719
Average prescription price

Avg: $305

ADAM SOUFLERIS MD

Infectious Disease

1,385

$844K

144
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 43%

$609
Average prescription price

Avg: $305

GAIL STANLEY M.D.

Infectious Disease

1,359

$1.09M

101
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 43%

$801
Average prescription price

Avg: $305

MARK CARR M.D.

Infectious Disease

1,356

$512K

103
50 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 43%

$378
Average prescription price

Avg: $305

PRISCILLA SIOSON-AHERRERA MD

Infectious Disease

1,312

$766K

227
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 43%

$584
Average prescription price

Avg: $305

DIMA YOUSSEF MD

Infectious Disease

1,309

$517K

117
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 43%

$395
Average prescription price

Avg: $305

JULI HORTON MD

Infectious Disease

1,297

$684K

130
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 43%

$527
Average prescription price

Avg: $305

HAL HILL MD

Infectious Disease

1,265

$719K

174
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 43%

$569
Average prescription price

Avg: $305

MARK ANDERSON MD

Infectious Disease

1,263

$870K

194
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 43%

$689
Average prescription price

Avg: $305

JULIE ANTIQUE MD

Infectious Disease

1,175

$352K

250
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 43%

$299
Average prescription price

Avg: $305

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank